CLIC2
protein-codingchloride intracellular channel 2, the group of Chloride intracellular channels
Gene summary
This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~58.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0010473
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010473
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010473
Submitter: Genomics England PanelApp
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
CLIC2 was first reported in relation to X-linked complex neurodevelopmental disorder in 2012 by Takano et al., PMID: 22814392. The three individuals (from two unrelated families) reported to date in the literature with variants in this gene had phenotypes including intellectual disability, delayed psychomotor development, seizures, and adult onset cardiac issues such as congestive heart failure, valvular insufficiency, atrial fibrillation, and cardiomegaly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, for the purposes of this curation, all of the reported disease entities, including syndromic X-linked mental retardation-32 (OMIM # 300886) and X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (ORPHA:324410, MONDO:0010473) have been lumped into one disease entity: X-linked complex neurodevelopmental disorder. Although two unique variants (both missense) have been reported in humans, the first published variant (Takano et al., PMID: 22814392) has been ruled out from disease-causality based on the presence of this variant in adult males in the (non-neuro) gnomAD population database (v.2.1.1). Given the dearth of experimental evidence linking CLIC2 with disease, and the scarcity of plausible reports of disease-causing variants in humans, the ClinGen Intellectual Disability and Autism Working Group recommended awarding 0 points for the second published variant, a missense change with no supportive functional data (Vissers et al., PMID: 28333917). In summary, there is disputed evidence supporting the relationship between CLIC2 and X-linked complex neurodevelopmental disorder. More evidence is needed to either support or refute the role CLIC2 plays in this disease. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 2/16/2021 (SOP Version 8).
Inheritance Pattern: XL
Disease ID:MONDO:0010473
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010473
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Musculoskeletal; Neurologic
Intervention: Cardiovascular
Rationale: Among other manifestations, individuals have been described as including cardiac findings such as atrial fibrillation, congestive heart failure, valvular insufficiency, and awareness may allow surveillance and early medical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CLIC2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001289.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 7 | 13 | |||
| missense | 44 | 6 | 50 | |||
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 0 | 0 | 65 | 13 | 0 | 78 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001280.3 | 6 | MANE Select | |
| Ensembl | ENSP00000358460.2 | 6 | MANE Select | |
| Ensembl | ENSP00000318558.4 | 4 | Standard | |
| Ensembl | ENSP00000619000.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pantoprazole Action Pathway
- Rabeprazole Action Pathway
- Esomeprazole Action Pathway
- Omeprazole Action Pathway
- Lansoprazole Action Pathway
Biological Process
- signal transduction
- regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- positive regulation of binding
- negative regulation of ryanodine-sensitive calcium-release channel activity
Molecular Function
- glutathione transferase activity
- glutathione peroxidase activity
- voltage-gated ion channel activity
- chloride channel activity
- protein binding
Cellular Component
- nucleus
- cytoplasm
- chloride channel complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000369449
- Coding exons
- 6
- Length
- 58467
- Individuals with no LoFs
- 125735
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 3
- Defined
- 125739
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.27 | 58 | 92.4 | 0.628 | 0.00000699 | 1632 |
| Missense (PolyPhen) | 14 | 41.398 | 0.33818 | 721 | ||
| Synonymous | 0.118 | 33 | 33.9 | 0.974 | 0.00000249 | 455 |
| Loss of Function | 1.43 | 3 | 7.13 | 0.421 | 4.46e-7 | 152 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000072 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000025 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Can insert into membranes and form chloride ion channels. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Modulates the activity of RYR2 and inhibits calcium influx. {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:15916532, ECO:0000269|PubMed:17945253}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, 32 (MRXS32) [MIM:300886]: A mental retardation syndrome characterized by profound intellectual deficit, delayed psychomotor development beginning in infancy and little or no speech development. Additional features include seizures, large joint contractures, and abnormal positioning of the thumbs. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:22814392}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- LoFtool
- 0.140
- RVIS EVS
- 0.19
- RVIS percentile EVS
- 66.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.903
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |